Trial Profile
An Open Label, Dose Titration Study of Sevelamer Carbonate Tablets & Powder in Hyperphosphatemic Chronic Kidney Disease Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Sevelamer (Primary)
- Indications Renal failure
- Focus Therapeutic Use
- Acronyms TOSCANA
- Sponsors Sanofi
- 10 Jan 2015 New trial record